Understanding CRVO

Central Retinal Vein Occlusion (CRVO)

Schedule Today

(973) 751-3284 Book Appointment
Rectangle 24
Rectangle 25

Understanding CRVO

This section explains what CRVO is and the different forms it can take.

CRVO happens when a blood clot obstructs the central retinal vein, trapping blood and fluid inside the retina. The resulting pressure and swelling often blur central vision, especially in people over age 50.

Doctors classify the condition into two distinct categories based on blood flow and severity.

  • Non-ischemic CRVO: The milder type, marked by mild leakage and blurred vision that can improve during the day. Visual acuity is often better than 20/200, and many patients recover good vision with monitoring and treatment.
  • Ischemic CRVO: The more severe type, where blood flow is greatly reduced. Extensive bleeding, cotton-wool spots, and severe vision loss can occur. Complications such as neovascular glaucoma are more common.

How CRVO Affects Vision

How CRVO Affects Vision

CRVO can quickly change how clearly you see, especially in one eye.

When fluid leaks into the macula, images become distorted or out of focus. Without enough oxygen, nerve cells may die, leading to sudden or permanent vision loss.

Symptoms vary based on the severity of the blockage.

  • Blurry or hazy vision
  • Sudden vision loss in one eye
  • Floaters that look like dark spots or lines
  • Redness or a feeling of pressure in severe cases

Diagnosis and Evaluation

Diagnosis and Evaluation

Accurate testing helps your eye doctor confirm CRVO and plan treatment.

Dilating eye drops allow the retina specialist to view the back of the eye for bleeding, swelling, and vessel changes. The exam is painless and takes only a few minutes.

Additional studies give detailed information about the health of the retina.

  • Optical Coherence Tomography (OCT) to measure macular swelling
  • Fluorescein angiography to track blood flow through retinal vessels
  • Vision tests to check sharpness and peripheral vision

Treatment Options

Several therapies aim to control swelling, improve vision, and prevent complications.

Medications such as bevacizumab, ranibizumab, or aflibercept reduce leakage and macular edema by lowering VEGF levels. Multiple injections are often required over time.

When swelling persists, steroids like triamcinolone or a dexamethasone implant may be used. Regular monitoring is needed because steroids can raise eye pressure or speed cataract formation.

Panretinal photocoagulation treats areas lacking blood flow to prevent abnormal vessel growth and lower the risk of neovascular glaucoma.

In selected cases, tissue plasminogen activator injections or vitrectomy surgery may be considered to address stubborn bleeding or traction on the retina.

Statistics and Prognosis

Statistics and Prognosis

Research offers insight into expected outcomes and the importance of follow-up care.

Studies show that more than 90 percent of ischemic CRVO cases result in severe vision loss below 20/200, while a minority of non-ischemic cases regain full vision.

Up to one-third of non-ischemic cases progress to the ischemic form within three years, highlighting the need for routine monitoring.

Risk Factors for CRVO

Risk Factors for CRVO

Certain health and lifestyle factors raise the likelihood of developing CRVO.

People over 50 and those with high blood pressure, diabetes, glaucoma, or high cholesterol face a higher risk because these conditions damage blood vessels.

Smoking, inactivity, and poor diet can worsen vascular health and increase the chance of clots forming in the retinal vein.

Blood-clotting disorders, autoimmune diseases, and some medications have been linked to vein occlusions and warrant careful medical review.

Causes of CRVO

Causes of CRVO

Several mechanisms can block the central retinal vein.

A thrombus inside the vein restricts flow and is a leading cause of CRVO, especially in people with clotting disorders.

Atherosclerosis and age-related vessel thickening can compress the vein, slowing circulation and promoting blockages.

Elevated eye pressure may squeeze the central retinal vein and trigger an occlusion.

Diabetes, hypertension, high cholesterol, and hyperviscosity syndromes make CRVO more likely by altering blood components and vessel walls.

In younger patients, vasculitis, migraines, infections, or eye trauma can sometimes obstruct the vein.

Potential Complications

Potential Complications

Untreated CRVO can lead to serious secondary problems.

Persistent fluid buildup in the macula blurs central vision and may lead to permanent loss if not controlled.

Oxygen deprivation can trigger fragile new vessels that raise eye pressure, cause pain, and further damage vision.

Frequently Asked Questions

Frequently Asked Questions

The answers below address common concerns patients have about CRVO.

Your retina specialist will classify your condition as non-ischemic or ischemic based on exam findings and imaging tests. This classification guides treatment and helps predict visual outcomes.

Anti-VEGF and steroid injections can improve or stabilize vision, but they require follow-up visits and carry small risks such as infection or increased eye pressure. Laser therapy lowers the chance of complications but may cause mild peripheral vision loss.

Most patients are seen every four to eight weeks during the initial treatment phase, then less frequently once the condition stabilizes. Your schedule will be customized to your response.

Repeat OCT scans, fluorescein angiography, or visual field tests may be ordered to track swelling, blood flow, and functional changes over time.

Managing blood pressure, blood sugar, and cholesterol, quitting smoking, exercising regularly, and eating a balanced diet all help protect retinal blood vessels and overall vision.

Caring for Your Vision

Prompt attention to Central Retinal Vein Occlusion can preserve sight and quality of life. Our team is dedicated to guiding you through diagnosis, treatment, and ongoing care so you can enjoy clear vision for years to come.